Kirsten Van Hoorde

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study

Ben Van Calster, Kirsten Van Hoorde, L. Valentin et al. · BMJ · 2014 · 501 citations · Full text

Medicine, Gynecology, Oncology +17

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors.

Ben Van Calster, Kirsten Van Hoorde, Wouter Froyman et al. · PubMed · 2015 · 104 citations · Full text

Medicine, Gynecology, Oncology +17

A spline-based tool to assess and visualize the calibration of multiclass risk predictions

Kirsten Van Hoorde, Sabine Van Huffel, D. Timmerman et al. · Journal of Biomedical Informatics · 2015 · 85 citations · Full text

Computing, Biostatistics, Data Science +14

Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two‐step triage protocol

Ben Van Calster, S. Bobdiwala, Sharmistha Guha et al. · Ultrasound in Obstetrics and Gynecology · 2016 · 80 citations · Full text

Medicine, Endocrinology, Obstetrics +17

Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies

Ben Van Calster, Y. Abdallah, Sharmistha Guha et al. · Human Reproduction · 2013 · 78 citations · Full text

Medicine, Gynecology, Obstetrics +16